Long-term efficacy of megestrol acetate and tamoxifen in a recurrent adult granulosa cell tumor of the ovary

por Moon, Ashley S., Dorigo, Oliver
Publicado 2021

ASCO 2019 meeting review

por Diver, Elisabeth, Dorigo, Oliver, Berek, Jonathan
Publicado 2019

Development of Therapeutic Vaccines for Ovarian Cancer

por Chow, Stephanie, Berek, Jonathan S., Dorigo, Oliver
Publicado 2020

Immunotherapeutic approaches to ovarian cancer treatment

por Chester, Cariad, Dorigo, Oliver, Berek, Jonathan S, Kohrt, Holbrook
Publicado 2015

Hemophagocytic lymphohistiocytosis as a paraneoplastic syndrome associated with ovarian dysgerminoma

por Nosratian-Baskovic, Mana, Tan, Brent, Folkins, Ann, Chisholm, Karen M., Dorigo, Oliver
Publicado 2016

Revealing the human mucinome

por Malaker, Stacy A., Riley, Nicholas M., Shon, D. Judy, Pedram, Kayvon, Krishnan, Venkatesh, Dorigo, Oliver, Bertozzi, Carolyn R.
Publicado 2022

Technetium Tc 99m tilmanocept fails to detect sentinel lymph nodes in endometrial cancer

por Reddy, Ravali A., Moon, Ashley S., Chow, Stephanie, Heilbroner, Lucas, Howitt, Brooke, Diver, Elisabeth, Dorigo, Oliver, Litkouhi, Babak, Renz, Malte, Karam, Amer
Publicado 2022

Screening cell mechanotype by parallel microfiltration

por Qi, Dongping, Kaur Gill, Navjot, Santiskulvong, Chintda, Sifuentes, Joshua, Dorigo, Oliver, Rao, Jianyu, Taylor-Harding, Barbie, Ruprecht Wiedemeyer, W., Rowat, Amy C.
Publicado 2015

CD24 signalling through macrophage Siglec-10 is a new target for cancer immunotherapy

por Barkal, Amira A, Brewer, Rachel E., Markovic, Maxim, Kowarsky, Mark, Barkal, Sammy A, Zaro, Balyn W., Krishnan, Venkatesh, Hatakeyama, Jason, Dorigo, Oliver, Barkal, Layla J, Weissman, Irving L.
Publicado 2019

Omental macrophages secrete chemokine ligands that promote ovarian cancer colonization of the omentum via CCR1

por Krishnan, Venkatesh, Tallapragada, Supreeti, Schaar, Bruce, Kamat, Kalika, Chanana, Anita M., Zhang, Yue, Patel, Sonia, Parkash, Vinita, Rinker-Schaeffer, Carrie, Folkins, Ann K., Rankin, Erinn B., Dorigo, Oliver
Publicado 2020

Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II Trial

por Dorigo, Oliver, Oza, Amit M., Pejovic, Tanja, Ghatage, Prafull, Ghamande, Sharad, Provencher, Diane, MacDonald, Lisa D., Torrey, Heather, Kaliaperumal, Valarmathy, Ebrahimizadeh, Walead, Hirsch, Heather A., Bramhecha, Yogesh, Villella, Jeannine, Fiset, Stephan
Publicado 2023

Classification of Molecular Subtypes of High-Grade Serous Ovarian Cancer by MALDI-Imaging

por Kassuhn, Wanja, Klein, Oliver, Darb-Esfahani, Silvia, Lammert, Hedwig, Handzik, Sylwia, Taube, Eliane T., Schmitt, Wolfgang D., Keunecke, Carlotta, Horst, David, Dreher, Felix, George, Joshy, Bowtell, David D., Dorigo, Oliver, Hummel, Michael, Sehouli, Jalid, Blüthgen, Nils, Kulbe, Hagen, Braicu, Elena I.
Publicado 2021

Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retros...

por Glajzer, Jacek, Castillo-Tong, Dan Cacsire, Richter, Rolf, Vergote, Ignace, Kulbe, Hagen, Vanderstichele, Adriaan, Ruscito, Ilary, Trillsch, Fabian, Mustea, Alexander, Kreuzinger, Caroline, Gourley, Charlie, Gabra, Hani, Taube, Eliane T., Dorigo, Oliver, Horst, David, Keunecke, Carlotta, Baum, Joanna, Angelotti, Timothy, Sehouli, Jalid, Braicu, Elena Ioana
Publicado 2022

Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathw...

por MacKay, Helen J., Levine, Douglas A., Bae-Jump, Victoria L., Bell, Daphne W., McAlpine, Jessica N., Santin, Alessandro, Fleming, Gini F., Mutch, David G., Nephew, Kenneth P., Wentzensen, Nicolas, Goodfellow, Paul J., Dorigo, Oliver, Nijman, Hans W., Broaddus, Russell, Kohn, Elise C.
Publicado 2017

Abdominal FLASH irradiation reduces radiation-induced gastrointestinal toxicity for the treatment of ovarian cancer in mice

por Levy, Karen, Natarajan, Suchitra, Wang, Jinghui, Chow, Stephanie, Eggold, Joshua T., Loo, Phoebe E., Manjappa, Rakesh, Melemenidis, Stavros, Lartey, Frederick M., Schüler, Emil, Skinner, Lawrie, Rafat, Marjan, Ko, Ryan, Kim, Anna, H. Al-Rawi, Duaa, von Eyben, Rie, Dorigo, Oliver, Casey, Kerriann M., Graves, Edward E., Bush, Karl, Yu, Amy S., Koong, Albert C., Maxim, Peter G., Loo, Billy W., Rankin, Erinn B.
Publicado 2020

Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial

por Gershenson, David M, Miller, Austin, Brady, William E, Paul, James, Carty, Karen, Rodgers, William, Millan, David, Coleman, Robert L, Moore, Kathleen N, Banerjee, Susana, Connolly, Kate, Secord, Angeles Alvarez, O'Malley, David M, Dorigo, Oliver, Gaillard, Stephanie, Gabra, Hani, Slomovitz, Brian, Hanjani, Parviz, Farley, John, Churchman, Michael, Ewing, Ailith, Hollis, Robert L, Herrington, C Simon, Huang, Helen Q, Wenzel, Lari, Gourley, Charlie
Publicado 2022

Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)

por Swisher, Elizabeth M., Kwan, Tanya T., Oza, Amit M., Tinker, Anna V., Ray-Coquard, Isabelle, Oaknin, Ana, Coleman, Robert L., Aghajanian, Carol, Konecny, Gottfried E., O’Malley, David M., Leary, Alexandra, Provencher, Diane, Welch, Stephen, Chen, Lee-may, Wahner Hendrickson, Andrea E., Ma, Ling, Ghatage, Prafull, Kristeleit, Rebecca S., Dorigo, Oliver, Musafer, Ashan, Kaufmann, Scott H., Elvin, Julia A., Lin, Douglas I., Chambers, Setsuko K., Dominy, Erin, Vo, Lan-Thanh, Goble, Sandra, Maloney, Lara, Giordano, Heidi, Harding, Thomas, Dobrovic, Alexander, Scott, Clare L., Lin, Kevin K., McNeish, Iain A.
Publicado 2021